Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Esperion Therapeutics Inc. logo

Esperion Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.68
 
USD
  
0.06
  
(2.29%)
Optionable: Yes  Market Cap: 500 M  90-day average vol: 6,383,664

Previous close: 2.62  Open: 2.64  Bid: 2.67  Ask: 2.68
52 week range    
0.70   
   3.34
Peers   
RARE / 
BMRN / 
FOLD / 
LXRX / 
PFE / 
Last updated: Friday 29th March 2024
50
MarketXLS Rank
40
Value
76
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ESPR Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-16 M-18 M-807000.0-30 M
(Increase) Decrease in other current liabilities2 M-490000.05 M-3 M22 M
(Increase) Decrease in other working capital1 M-1 M
(Increase) Decrease in payables-299000.0-1 M4 M16 M24 M-16 M23 M-34 M6 M9 M
(Increase) Decrease in receivables-12 M-11 M-11 M-15 M
Amortization of intangibles15000.029000.0
CapitalExpenditureReported873000.0325000.094000.019000.0151000.0953000.0869000.0
Cash at beginning of period57 M85 M77 M38 M34 M37 M167 M305 M259 M125 M
Cash at end of period85 M77 M38 M34 M37 M167 M305 M259 M125 M82 M
Cash flow-32 M-38 M-48 M-131 M-149 M-70 M-98 M-264 M-175 M-135 M
CashFlowFromContinuingInvestingActivities-37 M-160 M10 M-36 M140 M64 M21 M-50 M8 M43 M
ChangeInAccountPayable-299000.0-1 M4 M16 M24 M-16 M23 M-34 M6 M9 M
ChangeInAccruedExpense814000.0519000.06 M2 M8 M10 M3 M7 M4 M22 M
ChangeInPayablesAndAccruedExpense515000.0-814000.010 M18 M32 M-6 M26 M-27 M10 M31 M
ChangeInPrepaidAssets-264000.0-1 M139000.0-2 M-3 M-3 M-2 M99000.01 M6 M
ChangeInWorkingCapital251000.0-2 M10 M16 M29 M-7 M-4 M-53 M-3 M14 M
ChangesInAccountReceivables-12 M-11 M-11 M-15 M
CommonStockPayments-55 M
Depreciation160000.0236000.0252000.0258000.0300000.0300000.0500000.0600000.0500000.0200000.0
Depreciation unreconciled393000.0944000.01 M592000.083000.0100000.02 M2 M2 M1 M
DepreciationAndAmortization393000.0944000.01 M592000.083000.0100000.02 M2 M2 M1 M
FinancingCashFlow97 M191 M-2 M163 M11 M136 M202 M268 M33 M50 M
Free cash flow-33 M-38 M-48 M-131 M-149 M-71 M-86 M-264 M-175 M-135 M
GainLossOnSaleOfPPE31000.047000.0
Issuance of capital stock92 M190 M164 M10 M91 M4 M
IssuanceOfCapitalStock92 M190 M164 M10 M91 M4 M
IssuanceOfDebt5 M-638000.0-2 M-2 M-1 M272 M-440000.0
Net cash from financing activities97 M191 M-2 M163 M11 M136 M214 M268 M33 M50 M
Net cash from investing activities-37 M-160 M10 M-36 M140 M64 M21 M-50 M8 M43 M
Net cash from operating activities-32 M-38 M-48 M-131 M-149 M-70 M-85 M-264 M-175 M-135 M
Net change in cash & cash equivalents29 M-8 M-39 M-4 M3 M130 M138 M-46 M-134 M-43 M
Net income from continuing operations-36 M-50 M-75 M-167 M-202 M-97 M-144 M-269 M-234 M-209 M
NetCommonStockIssuance92 M190 M164 M-55 M10 M91 M4 M
NetInvestmentPropertiesPurchaseAndSale-36 M-160 M10 M-36 M141 M65 M22 M-50 M8 M43 M
NetInvestmentPurchaseAndSale-36 M-160 M10 M-36 M141 M65 M22 M-50 M8 M43 M
NetIssuancePaymentsOfDebt5 M-638000.0-2 M-2 M-1 M272 M-440000.0
NetLongTermDebtIssuance-638000.0-2 M-2 M-1 M272 M-440000.0
NetPPEPurchaseAndSale-861000.0-301000.0-94000.0-19000.0-151000.0-953000.0-869000.0
Operating (gains) losses31000.047000.0-3 M
Other financing charges net124 M-9 M46 M-58 M-15 M
Other investing changes net-12 M
Other non-cash items4 M13 M16 M19 M24 M34 M48 M58 M60 M59 M
ProceedsFromIssuanceOfWarrants78000.0209 M61 M
ProceedsFromStockOptionExercised473000.01 M45000.01 M12 M12 M7 M4 M
Purchase of Float term investments-36 M-281 M-197 M-220 M-25 M-34 M-4 M-50 M-60 M
Purchase of property plant & equipment-861000.0-301000.0-94000.0-19000.0-151000.0-953000.0-869000.0
Purchase of short term investments280 M
PurchaseOfInvestment-36 M-281 M-197 M-220 M-25 M-34 M-4 M-50 M-60 M
PurchaseOfPPE-873000.0-325000.0-94000.0-19000.0-151000.0-953000.0-869000.0
Repayment of debt-638000.0-2 M-2 M-1 M-8 M-440000.0
RepaymentOfDebt-638000.0-2 M-2 M-1 M-8 M-440000.0
Repurchase of capital stock-55 M
Revenue per share233000.0708000.01 M334000.0-217000.0-200000.02 M2 M2 M1 M
Sale of short term investments121 M207 M184 M166 M100 M39 M68 M43 M
SaleOfInvestment121 M207 M184 M166 M100 M39 M68 M43 M
SaleOfPPE12000.024000.0
StockBasedCompensation4 M13 M16 M19 M24 M26 M28 M24 M15 M12 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University